Pancreatic Cancer Research

Grant

Translational Studies for the Phase 1/2 Trial of VS-6766 + Defactinib and GEM + Nab-P in Metastatic PDAC

Fiscal years counted
2022

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try